Cargando…
Nuclear receptor 5A2 regulation of Agrp underlies olanzapine-induced hyperphagia
Antipsychotic (AP) drugs are efficacious treatments for various psychiatric disorders, but excessive weight gain and subsequent development of metabolic disease remain serious side effects of their use. Increased food intake leads to AP-induced weight gain, but the underlying molecular mechanisms re...
Autores principales: | Zapata, Rizaldy C., Zhang, Dinghong, Libster, Avraham, Porcu, Alessandra, Montilla-Perez, Patricia, Nur, Aisha, Xu, Baijie, Zhang, Zhi, Correa, Stephanie M., Liu, Chen, Telese, Francesca, Osborn, Olivia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412731/ https://www.ncbi.nlm.nih.gov/pubmed/36765131 http://dx.doi.org/10.1038/s41380-023-01981-9 |
Ejemplares similares
-
Cold-induced hyperphagia requires AgRP neuron activation in mice
por: Deem, Jennifer D, et al.
Publicado: (2020) -
Targeting Clic1 for the treatment of obesity: A novel therapeutic strategy to reduce food intake and body weight
por: Zapata, Rizaldy C., et al.
Publicado: (2023) -
Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding
por: Zapata, Rizaldy C., et al.
Publicado: (2022) -
Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain
por: Zapata, Rizaldy C., et al.
Publicado: (2021) -
Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
por: Fernø, Johan, et al.
Publicado: (2011)